Respiratory Syncytial Virus

Access to healthcare in sub-Saharan countries remains a challenge, resulting in profound inequities in health in the region. In response to these challenges, Julius Clinical and Julius Global Health (part of the University Medical Center Utrecht) have created Africa Clinical, a network of local clinical investigators and institutes who are committed to improving healthcare and specifically the health of the sub-Saharan population.

We established ReSViNET in 2014, and since 2018, ReSViNET has been a foundation — a financially and otherwise independent regulated entity. Julius Clinical works closely with ReSViNET to provide operational support to RSV clinical trials and observational studies. Our operational team has extensive experience in coordinating these studies, and ReSViNET has access to sites in countries across the globe, providing fast recruitment and high retention rates.